SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-22-001368
Filing Date
2022-01-11
Accepted
2022-01-11 16:46:55
Documents
3
Group Members
AARON ROYSTONCOREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP III, L.P.VENBIO GLOBAL STRATEGIC GP III, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc10032758_sc13g.htm SC 13G 194654
2 EXHIBIT 1 brhc10032758_ex1.htm EX-1 12918
3 EXHIBIT 2 brhc10032758_ex2.htm EX-2 5144
  Complete submission text file 0001140361-22-001368.txt   214414
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93228 | Film No.: 22524471
SIC: 2834 Pharmaceutical Preparations